Semin Thromb Hemost 2016; 42(06): 622-631
DOI: 10.1055/s-0036-1584132
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Risk Factors for Cerebral Venous Thrombosis

Suzanne M. Silvis
1   Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands
,
Saskia Middeldorp
2   Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
,
Susanna M. Zuurbier
1   Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands
,
Suzanne C. Cannegieter
3   Department of Clinical Epidemiology, Leiden University Medical Center, Amsterdam, The Netherlands
,
Jonathan M. Coutinho
1   Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands
› Author Affiliations
Further Information

Publication History

Publication Date:
06 June 2016 (online)

Abstract

Cerebral venous thrombosis (CVT) is a rare thrombotic disorder involving the cerebral veins and dural sinuses. In contrast to more common sites of venous thromboembolism (VTE), such as the legs and lungs, CVT mainly affects young adults and children, and women are affected three times more often than men. Although presenting symptoms are variable, headache is usually the first symptom, often in combination with focal neurologic deficits and epileptic seizures. The primary therapy for CVT consists of heparin followed by oral anticoagulation for at least 3 to 6 months. The mortality in the acute phase is 5 to 10% and a substantial proportion of survivors suffer from long-term disabilities. A large number of risk factors have been linked to CVT, although the scientific evidence for an association varies considerably between risk factors. Some risk factors, such as hereditary thrombophilia, correspond with risk factors for more common sites of VTE, whereas others, such as head trauma, are specific to CVT. In most patients, at least one risk factor can be identified. In this review, we provide an overview of the risk factors for CVT.

 
  • References

  • 1 Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke 2012; 43 (12) 3375-3377
  • 2 Janghorbani M, Zare M, Saadatnia M, Mousavi SA, Mojarrad M, Asgari E. Cerebral vein and dural sinus thrombosis in adults in Isfahan, Iran: frequency and seasonal variation. Acta Neurol Scand 2008; 117 (2) 117-121
  • 3 De Stefano V, Martinelli I. Splanchnic vein thrombosis: clinical presentation, risk factors and treatment. Intern Emerg Med 2010; 5 (6) 487-494
  • 4 White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107 (23) (Suppl. 01) I4-I8
  • 5 Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F ; ISCVT Investigators. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke 2005; 36 (9) 1927-1932
  • 6 Coutinho JM, Ferro JM, Canhão P , et al. Cerebral venous and sinus thrombosis in women. Stroke 2009; 40 (7) 2356-2361
  • 7 Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 5 (4) 692-699
  • 8 Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton III LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158 (6) 585-593
  • 9 Ungersböck K, Heimann A, Kempski O. Cerebral blood flow alterations in a rat model of cerebral sinus thrombosis. Stroke 1993; 24 (4) 563-569 , discussion 569–570
  • 10 Coutinho JM, Stam J, Canhão P, Barinagarrementeria F, Bousser MG, Ferro JM ; ISCVT Investigators. Cerebral venous thrombosis in the absence of headache. Stroke 2015; 46 (1) 245-247
  • 11 De Herdt V, Dumont F, Hénon H , et al. Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology 2011; 77 (20) 1794-1800
  • 12 Bladin CF, Alexandrov AV, Bellavance A , et al. Seizures after stroke: a prospective multicenter study. Arch Neurol 2000; 57 (11) 1617-1622
  • 13 Saposnik G, Barinagarrementeria F, Brown Jr RD , et al; American Heart Association Stroke Council and the Council on Epidemiology and Prevention. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42 (4) 1158-1192
  • 14 Ferro JM, Correia M, Pontes C, Baptista MV, Pita F ; Cerebral Venous Thrombosis Portuguese Collaborative Study Group (Venoport). Cerebral vein and dural sinus thrombosis in Portugal: 1980-1998. Cerebrovasc Dis 2001; 11 (3) 177-182
  • 15 Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F ; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35 (3) 664-670
  • 16 Leach JL, Fortuna RB, Jones BV, Gaskill-Shipley MF. Imaging of cerebral venous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics 2006; 26 (Suppl. 01) S19-S41 , discussion S42–S43
  • 17 Coutinho JM, van den Berg R, Zuurbier SM , et al. Small juxtacortical hemorrhages in cerebral venous thrombosis. Ann Neurol 2014; 75 (6) 908-916
  • 18 Einhäupl K, Stam J, Bousser MG , et al; European Federation of Neurological Societies. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol 2010; 17 (10) 1229-1235
  • 19 Einhäupl KM, Villringer A, Meister W , et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338 (8767) 597-600
  • 20 de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999; 30 (3) 484-488
  • 21 Coutinho J, de Bruijn SF, Deveber G, Stam J. Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database Syst Rev 2011; (8) CD002005
  • 22 Coutinho JM, Zuurbier SM, Stam J. Declining mortality in cerebral venous thrombosis: a systematic review. Stroke 2014; 45 (5) 1338-1341
  • 23 Canhão P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarrementeria F ; ISCVT Investigators. Causes and predictors of death in cerebral venous thrombosis. Stroke 2005; 36 (8) 1720-1725
  • 24 Koopman K, Uyttenboogaart M, Vroomen PC, van der Meer J, De Keyser J, Luijckx GJ. Long-term sequelae after cerebral venous thrombosis in functionally independent patients. J Stroke Cerebrovasc Dis 2009; 18 (3) 198-202
  • 25 Dentali F, Poli D, Scoditti U , et al; CErebral VEin Thrombosis International Study Investigators. Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost 2012; 10 (7) 1297-1302
  • 26 Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005; 352 (17) 1791-1798
  • 27 Coutinho JM. Cerebral venous thrombosis. J Thromb Haemost 2015; 13 (Suppl. 01) S238-S244
  • 28 Roach RE, Lijfering WM, Rosendaal FR, Cannegieter SC, le Cessie S. Sex difference in risk of second but not of first venous thrombosis: paradox explained. Circulation 2014; 129 (1) 51-56
  • 29 Peragallo Urrutia R, Coeytaux RR, McBroom AJ , et al. Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis. Obstet Gynecol 2013; 122 (2, Pt 1) 380-389
  • 30 Stegeman BH, de Bastos M, Rosendaal FR , et al. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ 2013; 347: f5298
  • 31 de Bruijn SF, Stam J, Koopman MM, Vandenbroucke JP ; The Cerebral Venous Sinus Thrombosis Study Group. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. BMJ 1998; 316 (7131) 589-592
  • 32 Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998; 338 (25) 1793-1797
  • 33 Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood 2006; 107 (7) 2766-2773
  • 34 Krayenbühl HA. Cerebral venous and sinus thrombosis. Clin Neurosurg 1966; 14: 1-24
  • 35 Zuurbier SM, Middeldorp S, Stam J, Coutinho JM. Sex differences in cerebral venous thrombosis: a systematic analysis of a shift over time. Int J Stroke 2016; 11 (2) 164-170
  • 36 Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004; 114 (5–6) 409-414
  • 37 Barco S, Nijkeuter M, Middeldorp S. Pregnancy and venous thromboembolism. Semin Thromb Hemost 2013; 39 (5) 549-558
  • 38 Cantú C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases. Stroke 1993; 24 (12) 1880-1884
  • 39 Sharshar T, Lamy C, Mas JL ; Stroke in Pregnancy Study Group. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke 1995; 26 (6) 930-936
  • 40 Kittner SJ, Stern BJ, Feeser BR , et al. Pregnancy and the risk of stroke. N Engl J Med 1996; 335 (11) 768-774
  • 41 Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. N Engl J Med 2008; 359 (19) 2025-2033
  • 42 Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000; 31 (6) 1274-1282
  • 43 Jeng JS, Tang SC, Yip PK. Incidence and etiologies of stroke during pregnancy and puerperium as evidenced in Taiwanese women. Cerebrovasc Dis 2004; 18 (4) 290-295
  • 44 Andersen BS, Steffensen FH, Sørensen HT, Nielsen GL, Olsen J. The cumulative incidence of venous thromboembolism during pregnancy and puerperium—an 11 year Danish population-based study of 63,300 pregnancies. Acta Obstet Gynecol Scand 1998; 77 (2) 170-173
  • 45 Soomro RM, Bucur IJ, Noorani S. Cumulative incidence of venous thromboembolism during pregnancy and puerperium: a hospital-based study. Angiology 2002; 53 (4) 429-434
  • 46 Cushman M, Kuller LH, Prentice R , et al; Women's Health Initiative Investigators. Estrogen plus progestin and risk of venous thrombosis. JAMA 2004; 292 (13) 1573-1580
  • 47 Vander T, Medvedovsky M, Shelef I, Duchano L, Tomer A, Herishanu Y. Postmenopausal HRT is not independent risk factor for dural sinus thrombosis. Eur J Neurol 2004; 11 (8) 569-571
  • 48 Lauw MN, Barco S, Coutinho JM, Middeldorp S. Cerebral venous thrombosis and thrombophilia: a systematic review and meta-analysis. Semin Thromb Hemost 2013; 39 (8) 913-927
  • 49 Vossen CY, Conard J, Fontcuberta J , et al. Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost 2004; 2 (9) 1526-1532
  • 50 Vossen CY, Conard J, Fontcuberta J , et al. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost 2005; 3 (3) 459-464
  • 51 Lijfering WM, Brouwer JL, Veeger NJ , et al. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood 2009; 113 (21) 5314-5322
  • 52 Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005; 293 (19) 2352-2361
  • 53 Coppens M, Reijnders JH, Middeldorp S, Doggen CJ, Rosendaal FR. Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis. J Thromb Haemost 2008; 6 (9) 1474-1477
  • 54 Howard LS, Hughes RJ. NICE guideline: management of venous thromboembolic diseases and role of thrombophilia testing. Thorax 2013; 68 (4) 391-393
  • 55 Grove WE. Septic and aseptic types of thrombosis of the cavernous sinus. Arch Otolaryngol 1936; 24: 29-50
  • 56 Hendrickson RG, Olshaker J, Duckett O. Rhinocerebral mucormycosis: a case of a rare, but deadly disease. J Emerg Med 1999; 17 (4) 641-645
  • 57 Turhan V, Senol MG, Sonmez G, Oncul O, Cavuslu S, Tanridag O. Cerebral venous thrombosis as a complication of leptospirosis. J Infect 2006; 53 (6) e247-e249
  • 58 Modi M, Singla V, Ahluwalia J , et al. HIV infection presenting as cerebral venous sinus thrombosis. Am J Emerg Med 2012; 30 (3) 517.e1-517.e3
  • 59 Siddiqi SA, Nishat S, Kanwar D, Ali F, Azeemuddin M, Wasay M. Cerebral venous sinus thrombosis: association with primary varicella zoster virus infection. J Stroke Cerebrovasc Dis 2012; 21 (8) 917.e1-917.e4
  • 60 Symonds CP. Otitic hydrocephalus: a report of three cases. BMJ 1932; 1 (3705) 53-54
  • 61 Zuurbier SM, van den Berg R, Troost D, Majoie CB, Stam J, Coutinho JM. Hydrocephalus in cerebral venous thrombosis. J Neurol 2015; 262 (4) 931-937
  • 62 Southwick FS, Richardson Jr EP, Swartz MN. Septic thrombosis of the dural venous sinuses. Medicine (Baltimore) 1986; 65 (2) 82-106
  • 63 Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 2003; 126 (Pt 5) 1015-1025
  • 64 Pfister HW, Borasio GD, Dirnagl U, Bauer M, Einhäupl KM. Cerebrovascular complications of bacterial meningitis in adults. Neurology 1992; 42 (8) 1497-1504
  • 65 Vergouwen MD, Schut ES, Troost D, van de Beek D. Diffuse cerebral intravascular coagulation and cerebral infarction in pneumococcal meningitis. Neurocrit Care 2010; 13 (2) 217-227
  • 66 MacFarlane JT, Cleland PG, Attai ED, Greenwood BM. Failure of heparin to alter the outcome of pneumococcal meningitis. BMJ 1977; 2 (6101) 1522
  • 67 Mook-Kanamori BB, Fritz D, Brouwer MC, van der Ende A, van de Beek D. Intracerebral hemorrhages in adults with community associated bacterial meningitis in adults: should we reconsider anticoagulant therapy?. PLoS ONE 2012; 7 (9) e45271
  • 68 Zuurbier SM, Coutinho JM, Stam J , et al; IISCVT Investigators. Clinical outcome of anticoagulant treatment in head or neck infection-associated cerebral venous thrombosis. Stroke 2016; 47 (5) 1271-1277
  • 69 Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton III LJ. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160 (6) 809-815
  • 70 Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293 (6) 715-722
  • 71 Cronin-Fenton DP, Søndergaard F, Pedersen LA , et al. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006. Br J Cancer 2010; 103 (7) 947-953
  • 72 Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases. Eur J Cancer 2013; 49 (6) 1404-1413
  • 73 Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol 2005; 6 (6) 401-410
  • 74 Rogers LR. Cerebrovascular complications in patients with cancer. Semin Neurol 2010; 30 (3) 311-319
  • 75 Caruso V, Iacoviello L, Di Castelnuovo A , et al. Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood 2006; 108 (7) 2216-2222
  • 76 Couturier MA, Huguet F, Chevallier P , et al. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience. Am J Hematol 2015; 90 (11) 986-991
  • 77 Zuurbier SM, Lauw MN, Coutinho JM , et al. Clinical course of cerebral venous thrombosis in adult acute lymphoblastic leukemia. J Stroke Cerebrovasc Dis 2015; 24 (7) 1679-1684
  • 78 Kreher S, Ochsenreither S, Trappe RU , et al; Haemostasis Working Party of the German Society of Hematology and Oncology; Austrian Society of Hematology and Oncology; Society of Thrombosis and Haemostasis Research. Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.). Ann Hematol 2014; 93 (12) 1953-1963
  • 79 De Stefano V, Fiorini A, Rossi E , et al. Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost 2007; 5 (4) 708-714
  • 80 Passamonti SM, Biguzzi E, Cazzola M , et al. The JAK2 V617F mutation in patients with cerebral venous thrombosis. J Thromb Haemost 2012; 10 (6) 998-1003
  • 81 Dentali F, Ageno W, Rumi E , et al. Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases. Thromb Res 2014; 134 (1) 41-43
  • 82 Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001; 85 (3) 430-434
  • 83 Danese S, Papa A, Saibeni S, Repici A, Malesci A, Vecchi M. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol 2007; 102 (1) 174-186
  • 84 Giannotta M, Tapete G, Emmi G, Silvestri E, Milla M. Thrombosis in inflammatory bowel diseases: what's the link?. Thromb J 2015; 13: 14
  • 85 Richard S, Fairise A, Lacour JC, Ducrocq X. Cerebral venous thrombosis in inflammatory bowel diseases. Inflamm Bowel Dis 2010; 16 (3) 366-367
  • 86 Samia BS, Lamia K, Fatma N , et al. Cerebral venous thrombosis in inflammatory bowel disease: a case series. Int J Colorectal Dis 2011; 26 (2) 257-258
  • 87 DeFilippis EM, Barfield E, Leifer D , et al. Cerebral venous thrombosis in inflammatory bowel disease. J Dig Dis 2015; 16 (2) 104-108
  • 88 Cognat E, Crassard I, Denier C, Vahedi K, Bousser MG. Cerebral venous thrombosis in inflammatory bowel diseases: eight cases and literature review. Int J Stroke 2011; 6 (6) 487-492
  • 89 Al-Araji A, Kidd DP. Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. Lancet Neurol 2009; 8 (2) 192-204
  • 90 Emmi G, Silvestri E, Squatrito D , et al. Thrombosis in vasculitis: from pathogenesis to treatment. Thromb J 2015; 13: 15
  • 91 Saadoun D, Wechsler B, Resche-Rigon M , et al. Cerebral venous thrombosis in Behçet's disease. Arthritis Rheum 2009; 61 (4) 518-526
  • 92 Aguiar de Sousa D, Mestre T, Ferro JM. Cerebral venous thrombosis in Behçet's disease: a systematic review. J Neurol 2011; 258 (5) 719-727
  • 93 Debeij J, Dekkers OM, Asvold BO , et al. Increased levels of free thyroxine and risk of venous thrombosis in a large population-based prospective study. J Thromb Haemost 2012; 10 (8) 1539-1546
  • 94 Debeij J, van Zaane B, Dekkers OM , et al. High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis: the MEGA study. J Thromb Haemost 2014; 12 (6) 839-846
  • 95 Verberne HJ, Fliers E, Prummel MF, Stam J, Brandjes DP, Wiersinga WM. Thyrotoxicosis as a predisposing factor for cerebral venous thrombosis. Thyroid 2000; 10 (7) 607-610
  • 96 Peralta AR, Canhão P. Hypothyroidism and cerebral vein thrombosis—a possible association. J Neurol 2008; 255 (7) 962-966
  • 97 Franchini M, Lippi G, Targher G. Hyperthyroidism and venous thrombosis: a casual or causal association? A systematic literature review. Clin Appl Thromb Hemost 2011; 17 (4) 387-392
  • 98 Vidailhet M, Piette JC, Wechsler B, Bousser MG, Brunet P. Cerebral venous thrombosis in systemic lupus erythematosus. Stroke 1990; 21 (8) 1226-1231
  • 99 Wang L, Chen H, Zhang Y , et al. Clinical characteristics of cerebral venous sinus thrombosis in patients with systemic lupus erythematosus: a single-centre experience in China. J Immunol Res 2015; 2015: 540738
  • 100 Cervera R, Khamashta MA, Font J , et al; European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003; 82 (5) 299-308
  • 101 Somers E, Magder LS, Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol 2002; 29 (12) 2531-2536
  • 102 Wysokinska EM, Wysokinski WE, Brown RD , et al. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology 2008; 70 (8) 627-633
  • 103 Narayan D, Kaul S, Ravishankar K , et al. Risk factors, clinical profile, and long-term outcome of 428 patients of cerebral sinus venous thrombosis: insights from Nizam's Institute Venous Stroke Registry, Hyderabad (India). Neurol India 2012; 60 (2) 154-159
  • 104 Miyakis S, Lockshin MD, Atsumi T , et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4 (2) 295-306
  • 105 Christopher R, Nagaraja D, Dixit NS, Narayanan CP. Anticardiolipin antibodies: a study in cerebral venous thrombosis. Acta Neurol Scand 1999; 99 (2) 121-124
  • 106 Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res 2006; 118 (3) 397-407
  • 107 Burns A, Wilson E, Harber M, Brunton C, Sweny P. Cerebral venous sinus thrombosis in minimal change nephrotic syndrome. Nephrol Dial Transplant 1995; 10 (1) 30-34
  • 108 Sung SF, Jeng JS, Yip PK, Huang KM. Cerebral venous thrombosis in patients with nephrotic syndrome—case reports. Angiology 1999; 50 (5) 427-432
  • 109 Xu H, Chen K, Lin D, Dai L, Chen H, Xu Z. Cerebral venous sinus thrombosis in adult nephrotic syndrome. Clin Nephrol 2010; 74 (2) 144-149
  • 110 Byrne JV, Lawton CA. Meningeal sarcoidosis causing intracranial hypertension secondary to dural sinus thrombosis. Br J Radiol 1983; 56 (670) 755-757
  • 111 Akova YA, Kansu T, Duman S. Pseudotumor cerebri secondary to dural sinus thrombosis in neurosarcoidosis. J Clin Neuroophthalmol 1993; 13 (3) 188-189
  • 112 Selvi A, Diakou M, Giannopoulos S, Zikou AK, Argyropoulou MI, Kyritsis AP. Cerebral venous thrombosis in a patient with sarcoidosis. Intern Med 2009; 48 (9) 723-725
  • 113 Mickle JP, McLennan JE, Lidden CW. Cortical vein thrombosis in Wegener's granulomatosis. Case report. J Neurosurg 1977; 46 (2) 248-251
  • 114 Enevoldson TP, Russell RW. Cerebral venous thrombosis: new causes for an old syndrome?. Q J Med 1990; 77 (284) 1255-1275
  • 115 Stolz E, Valdueza JM, Grebe M , et al. Anemia as a risk factor for cerebral venous thrombosis? An old hypothesis revisited. Results of a prospective study. J Neurol 2007; 254 (6) 729-734
  • 116 Coutinho JM, Zuurbier SM, Gaartman AE , et al. Association between anemia and cerebral venous thrombosis: case-control study. Stroke 2015; 46 (10) 2735-2740
  • 117 Hill A, Kelly RJ, Hillmen P. Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood 2013; 121 (25) 4985-4996 , quiz 5105
  • 118 Meppiel E, Crassard I, Peffault de Latour R , et al. Cerebral venous thrombosis in paroxysmal nocturnal hemoglobinuria: a series of 15 cases and review of the literature. Medicine (Baltimore) 2015; 94 (1) e362
  • 119 Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995; 333 (19) 1253-1258
  • 120 Canhão P, Batista P, Falcão F. Lumbar puncture and dural sinus thrombosis—a causal or casual association?. Cerebrovasc Dis 2005; 19 (1) 53-56
  • 121 Aidi S, Chaunu MP, Biousse V, Bousser MG. Changing pattern of headache pointing to cerebral venous thrombosis after lumbar puncture and intravenous high-dose corticosteroids. Headache 1999; 39 (8) 559-564
  • 122 Wilder-Smith E, Kothbauer-Margreiter I, Lämmle B, Sturzenegger M, Ozdoba C, Hauser SP. Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis. J Neurol Neurosurg Psychiatry 1997; 63 (3) 351-356
  • 123 Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 2002; 162 (10) 1182-1189
  • 124 Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008; 117 (1) 93-102
  • 125 Zuurbier SM, Arnold M, Middeldorp S , et al. Risk of cerebral venous thrombosis in obese women. JAMA Neurol 2016; (e-pub ahead of print). doi:10.1001/jamaneurol.2016.0001
  • 126 Christiansen SC, Lijfering WM, Naess IA , et al. The relationship between body mass index, activated protein C resistance and risk of venous thrombosis. J Thromb Haemost 2012; 10 (9) 1761-1767
  • 127 Rosing J, Middeldorp S, Curvers J , et al. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study. Lancet 1999; 354 (9195) 2036-2040
  • 128 Delgado Almandoz JE, Kelly HR, Schaefer PW, Lev MH, Gonzalez RG, Romero JM. Prevalence of traumatic dural venous sinus thrombosis in high-risk acute blunt head trauma patients evaluated with multidetector CT venography. Radiology 2010; 255 (2) 570-577
  • 129 Morales H, Jones BV, Leach JL, Abruzzo TA. Documented development of a dural arteriovenous fistula in an infant subsequent to sinus thrombosis: case report and review of the literature. Neuroradiology 2010; 52 (3) 225-229
  • 130 Tsai LK, Jeng JS, Liu HM, Wang HJ, Yip PK. Intracranial dural arteriovenous fistulas with or without cerebral sinus thrombosis: analysis of 69 patients. J Neurol Neurosurg Psychiatry 2004; 75 (11) 1639-1641
  • 131 Lai PH, Li JY, Lo YK, Wu MT, Liang HL, Chen CK. A case of spontaneous intracranial hypotension complicated by isolated cortical vein thrombosis and cerebral venous infarction. Cephalalgia 2007; 27 (1) 87-90
  • 132 Berroir S, Grabli D, Héran F, Bakouche P, Bousser MG. Cerebral sinus venous thrombosis in two patients with spontaneous intracranial hypotension. Cerebrovasc Dis 2004; 17 (1) 9-12
  • 133 deVeber G, Andrew M, Adams C , et al; Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345 (6) 417-423
  • 134 Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyperhomocysteinemia in cerebral vein thrombosis. Blood 2003; 102 (4) 1363-1366
  • 135 Lichy C, Dong-Si T, Reuner K , et al. Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems. J Neurol 2006; 253 (3) 316-320
  • 136 Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol 2002; 70 (2) 126-132